As a part of the U.S. government, the U.S. Food and Drug Administration (FDA) are responsible for protecting consumer health by ensuring the efficiency, safety, security of drugs, biological products and medical services. It’s also responsible for the nation’s food supply, etc.
FDA Takes Down Many Unapproved Drugs For Cancer Treatment
In the medical sector, FDA plays a very important role in approving drugs and medicines for public use. Every year the state approves much new consumption of drugs in cancer treatment. It’s basically based on their early signs that they can help in slowing down the spread of cancer.
The initial results which came by are different when it’s time for the secondary stage. Is it making any efforts in making life long for the cancer patients? There are many uncleared debates upon these drugs.
To make it clear FDA has reviewed the drugs and their cases that is after a gap of 10 years. FDA announces that several drugs which were approved for cancer treatment were useless and didn’t contribute to improving the condition.
At first, these were approved only because of their innovative shortcuts to speed up the condition of really ill patients, and after much research, they concluded that these medicines and drugs failed in the medications which were promised earlier of the positive outcome.
Results this the stock which was already stored by the hospitals and chemist shops are at a loss. A cancer specialist and bioethicist at the University of Pennsylvania, Dr. Ezekiel Emanuel, said that The doctors prescribe these drugs to their patients and the patients were taking them without any second thought. He said it was affected by very serious problems, so it’s better to regulate these drugs before it’s late.
According to the reports, the U.S. spends more on the prescription of drugs than any other country. And it has doubled in cancer treatment drugs since 2013 to over 60 billion dollars per annum. And according to the IQVIA firm, the prices of new medication and drugs are much high; that is, its cost is around 90,000 dollars to 300,000 a year, and the prices are increasing faster than the recovery of a patient.
After so many reports and because of rising prices of these drugs, finally, FDA prohibited these drugs expenses from accounts and eventually, it vanished from the market. The cancer specialist at the University of California, Dr Vinay Prasad, says that it’s a very good decision taken by the FDA, as now we can ask about the truthfulness of the drug, and also it’s worth spending so much on it.
FDA decides to talk with the drug-makers and take advice from the cancer experts and also hear their presentations about the failed product, and there is a chance that maybe the drugs are not completely ineffective. After all this researches FDA will make its final decision.
But since last year, after consulting FDA, 4 drugmakers have already taken down the approval for lung and bladder cancer as every drug has failed to match their standards In improving the condition of the patients. According to the FDA in 2018 report, 5 % of accelerated drugs were unapproved, and 55% are verified.
According to Harvard researchers, they found that 20 % of drugs from the total has shown instances for improving cancer conditions. So still, it’s not clear if some drugs are approved or not. Why the approval of drugs done on initial data?
In 1992, Congress gave a right to approve the drug based on preliminary data because of a protest going on for the drug development for HIV patients. And after this rule, the Medicine industry paced up, and also the prices dropped down.